SVA
NASDAQ · Biotechnology
Sinovac Biotech Ltd
$6.47
+0.00 (+0.00%)
Open$6.47
Previous Close$6.47
Day High$6.47
Day Low$6.47
52W High$6.47
52W Low$6.47
Volume—
Avg Volume0
Market Cap639.90M
P/E Ratio—
EPS$-1.25
SectorBiotechnology
Key Financials
| FY 2026 | FY 2025 | |
|---|---|---|
| Revenue | 445.10M | 464.96M |
| Net Income | -99,209,845 | -93,271,555 |
| Profit Margin | -22.3% | -21.2% |
| EBITDA | -94,749,309 | -94,026,787 |
| Free Cash Flow | — | — |
| Rev Growth | -4.3% | -4.3% |
| Debt/Equity | 0.03 | 0.03 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $283.48 | +3.32% | 76.3 | 481.40B |
| AMGN | Amgen Inc | $438.66 | +2.95% | 25.2 | 220.28B |
| GILD | Gilead Sciences Inc | $158.39 | +3.16% | — | 185.61B |
| VRTX | Vertex Pharmaceuticals Inc | $513.05 | +2.92% | 29.0 | 127.55B |
| REGN | Regeneron Pharmaceuticals | $797.84 | +2.50% | 17.6 | 76.14B |
| ALNY | Alnylam Pharmaceuticals Inc | $224.47 | +0.29% | 37.2 | 30.04B |